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The penicillin-resistant Enterococcus hirae R40 has a typical profile of membrane-bound penicillin-binding proteins
(PBPs) except that the 71 kDa PBP5 of low penicillin affinity represents about 50 % of all the PBPs present. Water-soluble
tryptic-digest peptides were selectively produced from PBP5, their N-terminal regions were sequenced and synthetic
oligonucleotides were used as primers to generate a 476 bp DNA fragment by polymerase chain reaction. On the basis
of these data, the PBP5-encoding gene was cloned in Escherichia coli by using pBR322 as vector. The gene, included in
a 7.1 kb insert, had the information for a 678-amino acid-residue protein. PBP5 shows similarity, in the primary structure,
with the high-molecular-mass PBPs of class B. In particular, amino acid alignment of the enterococcal PBP5 and the
methicillin-resistant staphylococcal PBP2' generates scores that are 30, for the N-terminal domains, and 53, for the C-
terminal domains, standard deviations above that expected for a run of 20 randomized pairs of proteins having the same
amino acid compositions as the two proteins under consideration.
INTRODUCTION
Bacteria possess multiple membrane-bound proteins that bind
penicillin in the form of stable serine-ester-linked penicilloyl
derivatives [1]. The penicillin-binding proteins (PBPs) fall in two
major groups. The monofunctional low-molecular-mass PBPs
are active-site-serine DD-peptidases; they probably control the
extent of wall peptidoglycan cross-linking. The high-molecular-
mass PBPs are two-domain proteins in which the active-site-
serine-containing penicillin-binding C-terminal domain is pre-
ceded by a several-hundred-amino acid-residue N-terminal ex-
tension [1,2]. They fulfil multiple functions. In Bacillus licheni-
formis the high-molecular-mass PBP BLAR is the penicillin
sensory-transducer required for the specific inducibility of f8-
lactamase synthesis [3,4]. PBPs IA and lB of Escherichia coli
catalyse peptidoglycan transglycosylation (presumably at a site
in the N-terminal domain) and peptidoglycan transpeptidation
(presumably at the serine-containing site of the C-terminal
domain) [2]. PBPs 2 and 3 of Esch. coli, in conjunction with other
life-cycle proteins, play important roles in cell division and
determination of cell shape [1,2,5-9].
Resistance to ,J-lactam antibiotics may arise by the acquisition
of a novel PBP of low penicillin affinity, for example the PBP2'
of Staphylococcus aureus [10-12], or by the introduction of
multiple amino acid substitutions resulting in the remodelling of
the penicillin-binding domain of some targeted high-molecular-
mass PBPs, for example the PBPs 3 of Escherichia coli [13], 2B
and 2X of Streptococcus pneumoniae [14-16] and 2 of Neisseria
gonorrhoeae and Neisseria meningitidis [17-20]. Sequence-simi-
larity searches suggest that these high-molecular-mass PBPs are
related to each other and probably form a distinct class B of
PBPs of great physiological importance [1,16].
The relatively low susceptibility to penicillin of Enterococcus
hirae A.T.C.C. 9790 [21] and Ent. hirae S185, a clinical isolate
from pig intestine [22], has been attributed to the presence of a
high-molecular-mass PBP of low affinity for the drug, the 71 kDa
PBP5 and the 77 kDa PBP3r respectively. Laboratory mutants
have been obtained that overproduce PBP5 (Ent. hirae R40) and
PBP3r (Ent. hirae S185r) and, in parallel with this, have a much
increased penicillin-resistance [21,22]. Experiments were under-
taken with the aim of unravelling the primary structure of the
Ent. hirae R40 PBP5.
MATERIALS AND METHODS
Bacterial strains
Ent. hirae strains R40 and Revl4 [21,23] were gifts from Dr.
R. Fontana and Dr. P. Canepari (University of Verona, Verona,
Italy). MAX Efficiency Esch. coli DH5SaF'IQ competent strain
was from Bethesda Research Laboratories (Gaithersburg MD,
U.S.A.). Esch. coli HB1I1 and JM105 were also used.
Membranes
Ent. hirae cells were grown unshaken at 37 °C in 500 ml of SB
medium [24] and collected at the late exponential phase
(A550 = 6.0). The membranes were prepared as described pre-
viously [22,24,25]. The proteins were measured by the Lowry
method as modified by Coyette et al. [26].
Labelling with benzyll'4Cjpenicillin, SDS/PAGE and
fluorography
Samples were labelled with benzyl[14C]penicillin (54 Ci/mol;
Amersham International, Amersham, Bucks., U.K.) and sub-
mitted to SDS/PAGE. Fluorography of the gels and estimation
of the PBPs by densitometry of the fluorograms were performed
as described previously [22,25]. Mean values (ten assays) of
the molecular masses of the PBPs were determined by using
BSA (66.3 kDa), ovalbumin (42.7 kDa), Streptomyces R61 DD-
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carboxypeptidase (38 kDa), carbonic anhydrase (29 kDa), myo-
globin CNBr-cleavage products (17.2, 14.6, 8.24, 6.4 and
2.6 kDa) and hen egg-white lysozyme (14 kDa) as standards.
The values of the second-order rate constant of protein acylation
and first-order rate of protein deacylation were measured, and
the antibiotic concentrations and incubation times necessary to
achieve a given extent of saturation of the PBPs were calculated
as described previously [27,28].
Purification of the PBP5 tryptic-digest derivatives and amino
acid microsequencing
The PBP5 tryptic-digest derivatives, referred to as t-PBP5s,
were purified essentially as described by Piras et al. [22] but with
the following modifications. (1) The Q-Sepharose column was
equilibrated and eluted with 25 mM-Tris/borate buffer, pH 8.0.
(2) Fractions from the first chromatography were concentrated
to 15 ml, dialysed, divided into 5 ml samples and filtered on a
1 ml MonoQ HR 5/5 column equilibrated with 20 mM-Bistris/
HCI buffer, pH 6.3, and eluted with the same buffer and an NaCl
gradient (0-1 M). (3) Fractions from step (2) were concentrated
to 2 ml by ultrafiltration, adjusted to 0.85 M-(NH4)2SO4 in 50 mM-
sodium phosphate buffer, pH 7.0, and filtered on the phenyl-
Superose column used previously [22]. Each step of the purifica-
tion procedure was monitored by SDS/PAGE of samples pre-
viously labelled with benzyl[14C]penicillin. Electroblotted pep-
tides were microsequenced as described by Piras et al. [22].
Antibodies and immunoassays
Adult rabbits were injected subcutaneously with a preparation
emulsified in complete Freund's adjuvant and containing 80 ,ug
(total amount) of several peptide fragments of PBP5 purified
from Ent. hirae R40 [29]. The same injection was repeated fqur
times at 15-day intervals. A final injection was made with a
preparation containing 140 ,ug of 67 kDa and 63 kDa peptide
fragments ([29] and the Results section) in a ratio of 4:1.
Elimination of non-specific antibodies was made by immuno-
adsorption of the antiserum by using a mixture of Esch. coli
HBIOI and Ent. hirae Revl4 cell lysates as described below.
(Note that strain Rev14 lacks PBP5.)
Late-exponential-phase cells of Esch. coli and Ent. hirae
Rev14 were collected separately from 1-litre cultures and re-
suspended separately in 50 ml of lysozyme solution (1 mg/ml).
The Esch. coli cell suspension was supplemented with 5 mm-
EDTA and kept on ice for 30 min. The Revl4 cell suspension
was incubated at 37 °C for 30 min. The two cell lysates were
mixed and the final 100 ml preparation was (i) boiled for 15 min
in a microwave oven, (ii) cooled and treated for 30 min at 37 °C
with 2 mg ofDNAase and 2 mg of RNAase, (iii) boiled for 5 min
as above, (iv) cooled and shaken for 90 min at 22 °C in the
presence of a 30 cm x 30 cm nitrocellulose sheet cut into small
pieces, (v) supplemented with 1.5 g of BSA, 1.5 ml of 1% (w/v)
NaN3, 30 ml of water and 15 ml of 10 x TBS (5 M-Nacl/200 mm-
Tris/HCI buffer, pH 7.5), and (vi) incubated at 22 °C for 30 min.
The antiserum was diluted 100-fold in the mixture and shaken
for 16 h at 22 'C. After centrifugation (40000 g for 20 min), the
purified antiserum was diluted 50-fold with TTBS [TBS con-
taining 0.05 % (v/v) Tween 20 and 1 % (w/v) BSA] before use.
Immunodetection was performed on proteins or peptides trans-
ferred from polyacrylamide slab gels on to 0.45 ,um-pore-size
Millipore HA type nitrocellulose sheets as described by Piras
et al. [22].
DNA recombinant techniques and nucleotide sequencing
Restriction endonucleases, T7 DNA polymerase, calf intestinal
alkaline phosphatase and T4 DNA ligase were from Boehringer
(Mannheim, Germany) and Bethesda Research Laboratories
(Gaithersburg, MD, U.S.A.). [y-32P]dATP and [a-[35S]thio]ATP
were from Amersham International and ampicillin was from
Beecham (Brussels, Belgium). Oligonucleotides were synthesized
by Eurogentec (Liege, Belgium). The Ent. hirae R40 chromo-
somal DNA was prepared as described previously [30]. This
procedure includes treatments with lysozyme in the presence of
sucrose, SDS and proteinase K. Preparation of plasmid DNA,
transformation of Esch. coli, digestion of DNA with restriction
enzymes, treatment with calf intestinal alkaline phosphatase,
ligation and agarose-gel electrophoresis of plasmids and digested
DNAs were performed essentially as described by Sambrook
et al. [31]. DNA fragments were purified by using the Geneclean
procedure (Bio-101, La Jolla, CA, U.S.A.), subcloned into
bacteriophages M13mpl 8 and M13mp19 and sequenced with the
Sequenase kit (U.S. Biochemical Corp., Cleveland, OH, U.S.A.)
by using the dideoxynucleotide chain-termination method [32].
Amplification by PCR
PCR amplification was performed as described by Piras et al.
[22] except that before the first cycle the DNA template was
treated at 94 °C for 5 min and after the 30th cycle the time at
72 °C was 7 min. The PCR reaction product (i.e. a 476 bp DNA
segment) was (i) submitted to PAGE (6% acrylamide) in non-
denaturing TBE buffer (1 mM-EDTA/40 mM-Tris/borate buffer,
pH 8 in a Bio-Rad Mini Protean apparatus, (ii) electroeluted
from the gel in 10 mM-Tris/HCI buffer, pH 8.0, containing 5 mm-
NaCl and 1 mM-EDTA, (iii) extracted twice with phenol/
chloroform (1:1, v/v) and precipitated with ethanol, (iv)
digested with BamHI and EcoRI restriction enzymes (Bethesda
Research Laboratories), and (v) cloned in bacteriophages
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Fig. 1. SDS/PAGE of the Ent. hirae R40 membrane-bound PBPs (a) and
the water-soluble PBP5 tryptic-digest peptides (b)
Conditions of electrophoresis: (a) 7.2% (w/v) acrylamide; 16 h; gel
length 32 cm; (b) 8.5% (w/v) acrylamide; 5 h; gel length 16 cm. (a)
Membranes (200 ,ug of protein) were labelled with 100 jaM-benzyl-
['4C]penicillin for 60 min either directly (lane 1) or after previous
treatment with 15 jaM non-radioactive benzylpenicillin for 10 min
(lane 2), and the PBPs were detected by fluorography of the gels.
Immunodetection (lane 3) ofPBP5 in isolated membranes (100 ,jg of
total protein) with the anti-PBP5 serum was also performed. (b)
Isolation of the 60 kDa t-PBP5 (lanes 4, 7 and 10), the 67 kDa t-
PBP5 (lanes 5, 8 and 11) and tryptic digestion of the purified 67 kDa
t-PBP5 (lanes 6, 9 and 12). The peptides seen by fluorography in
lanes 4-6 (5 jag, 2 jag and 10 jag respectively) were labelled with




Sequence of Enterococcus hirae penicillin-binding protein 5
DH5aF'IQ competent cells were used for the transformation
experiments.
RESULTS
Specific labelling of PBP5 in Ent. hirae R40 membranes with
benzy1l"4C1penicillin
Ent. hirae R40 contains the six species-specific membrane-
bound PBPs [33]: PBP1 (119 + 8 kDa), PBP2 (84+ 1.7 kDa),
PBP3 (77 + 0.6 kDa), PBP4 (75 + 0.7 kDa), PBP5 (71 + 0.7 kDa)
and PBP6 (43±1 kDa) (Fig. 1, lane 1). When compared with
Ent. hirae A.T.C.C. 9790, the peculiarity of Ent. hirae R40 is that
(1) 67 kDa t-PBP5: TISEKEALEKYQNIYGAVAIKGLEISN...
(2) 60 kDa t- PB P5: INWQPNLIFPQKEDKVSLTSEEAXGDILDRNGKKLA...
(3) 44 kDa t-PBP5: NAELSXNGKIGRSGLENTrYDKELRGTNGGKLSITDADG...
(4) 32 kDa t-PB P5: MTNGISQEDYQAYTNKDQPFI...
(5) 30 kDa t- PBP5: DQPFISRFATGYAXGSTFKMITAAIGLDNQTLNP...
Fig. 2. N-Terminal amino acid sequences of the PBP5 tryptic-digest
fragments
The underlined sequences were those on the basis of which the two
oligonucleotides shown in Fig. 3 were synthesized. Note the overlap
DQPFI between the 32 kDa t-PBP5 and the 30 kDa t-PBP5.
the 71 kDa PBP5 of low penicillin affinity represents about one-
half of all the PBPs present. In order to map out fragments
specifically produced by tryptic digestion ofPBP5, membranes of
Ent. hirae R40 were prepared in which PBP5 was virtually the
only PBP to be labelled with benzyl[14C]penicillin (Fig. 1, lane 2).
For this purpose membranes were treated first with 15 tM non-
radioactive benzylpenicillin for 10 min at 37 °C (under which
conditions PBPs 1, 2, 3 and 4 were fully saturated, PBP6 was
saturated by 90% and PBP5 remained in a free form), and then
with 100 ,uM-benzyl[14C]penicillin for 60 min at 37 °C, thus
achieving complete labelling of PBP5.
Tryptic digestion of the Ent. hirae R40 membranes: the 67 kDa
t-PBP5 and 60 kDa t-PBP5 tryptic-digest fragments
It was known that PBP5 could be quantitatively converted
into water-soluble penicillin-binding derivatives by trypsin treat-
ment of isolated membranes of Ent. hirae R40 [29,34]. On the
basis of these data, a membrane suspension [1.5 g of total protein
in 120 ml of 40 mM-sodium phosphate buffer, pH 6.5, containing
1 mM-MgCl2 and 3 % (v/v) glycerol] was incubated with 0.5 %
(w/w) trypsin (type XI; Sigma Chemical Co.) for 15 min at
37 'C. The reaction was stopped by addition of 10 mg ofsoyabean
trypsin inhibitor, and the preparation was submitted to ultra-
centrifugation at 105 000 g for 1 h.
Analysis of the supernatant showed that, as a result of this
relatively mild proteolytic treatment, 85 % of the membrane-
bound PBP5 (initial amount 120 nmol or 8.3 mg) was converted
into four water-soluble fragments, of 67 +0.6 kDa (55 %),
Oligonucleotide 1
G
G G G A T C C C AAA T G G AAG ATA CAG ATAA
/ BamH c
Q M E D T D K V S L T S E E A K R G D I L
GGATCCCAGATGGAAGACACGGATAAAGTAAGTCTGACTAGTGAGGAAGCTAAAAGAGGCGATATCCTTG
10 20 30 40 50 60 70
D R N G K K L A T T G K L K Q L G I V P R K L G
ATCGAAATGGAAAGAAATTAGCAACGACGGGCAAATTGAAACAGTTAGGGATCGI!CCTAGAAAGCTGG
80 90 100 110 120 130 140
E K E E K T A N I K A I A A A F D L S E D E I
AGAAAAAGAAGAGAAAACAGCAAACATCAAAGCAATTGCTGCAGCTTTTGATCTTTCAGAAGATGAAATC
150 160 170 190 200 210
PstI




T P E L P S G A A I Q E V D G R T Y P L G E A A
CCCCCGAATTGCCAAGTGGAGCAGCGATCCAAGAAGTTGATGGTCGCACCTATCCGTTAGGCGAAGCAGC
290 300 310 320 330 340 350
G Q L I G Y V G D I S A E D I K K N A E L S S
AGGCCAATTGATTGGTTATGTTGGTGATATCTCAGCAGAAGATATCAAAAAGAATGCTGAATTAAGTAGT
360 370 380 390 400
N G K I G R S G L E M T Y D K E L
AATGGTAAAATTGGtCnLi~cAAATGAcTrATGAAAAGAAcTGAATrc
430 440 450 460 470
G
CTTTACTG T ATACTA TTC CTT A ACTTAAGG
C EcoRI
Oligonucleotide 2
Fig. 3. Oligonucleotides used as primers for PCR amplification, PCR product and amino acid sequence of PBPS-PCR
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63 + 0.7 kDa (14 %), 60+ 1.4 kDa (7 o) and 44+ 1.2 kDa (9 %).
The fragments bound benzyl['4C]penicillin with a low affinity
comparable with that of the membrane-bound PBP5 (see below).
They had apparent molecular masses comparable with those of
the radioactive fragments obtained from membranes whose PBP5
had been selectively labelled with benzyl['4C]penicillin before
trypsin treatment.
The 67 kDa t-PBP5 tryptic-digest fragment was isolated and
the 60 kDa t-PBP5 fragment was partially purified (see the
Materials and methods section). (1) The supernatant fraction
(120 ml; 860 mg of protein) was filtered on the Q-Sepharose FF
column and the four aforementioned tryptic-digest fragments
were eluted at 0.19-0.24 M-NaCl, with a 20-fold specific en-
richment. (2) The pooled fractions (treated as described in the
Materials and methods section) were filtered on the 1 ml MonoQ
HR5/5 column. Elution with the NaCl gradient yielded two
fractions. Fraction A, which was eluted at 0.21-0.24 M-NaCl,
was considerably enriched in the 67 kDa t-PBP5. Fraction B,
which was eluted at 0.19-0.21 M-NaCl, contained almost equiva-
lent amounts of 67 kDa t-PBP5 and 60 kDa t-PBP5 plus much
smaller amounts of 44 kDa t-PBP5. (3) Fraction A and fraction
B (treated as described in the Materials and methods section)
were loaded on to the phenyl-Superose HR5/5 column. The
60 kDa t-PBP5 from fraction B was eluted at 0.3-0.15 M-
(NH4)2SO04 It was about 85 % pure (Fig. 1, lanes 4 and 7). The
67 kDa t-PBP5 from fraction A was eluted at an (NH4)2SO4
concentration of less than 0.15 M. It was at least 95 % pure (Fig.
1, lanes 5 and 8).
Tryptic digestion of the purified 67 kDa t-PBP5: the 44 kDa
t-PBP5, 35 kDa t-PBP5, 32 kDa PBP5 and 30 kDa t-PBP5
tryptic-digest fragments
The 67 kDa t-PBP5 (0.4 mg in 0.4 ml of 40 mM-sodium phos-
phate buffer, pH 6.5, containing 1 mM-MgCI2) was incubated
with 10% (w/w) trypsin for 60 min at 37 'C. As a result of this
drastic proteolytic treatment, the 67 kDa t-PBP5 was degraded
into six fragments (Fig. 1, lane 9). Fragments of molecular mass
smaller than 30 kDa lacked penicillin-binding capacity (Fig. 1,
lanes 6 and 9). With the procedure described previously [27,28],
the membrane-bound PBP5 and the 67 kDa, 60 kDa and 44 kDa
fragments reacted with benzylpenicillin with the same low second-
order rate constant of protein acylation (5-9 M-1 s-1) and the
same low first-order rate constant of protein deacylation
(6 x 10--1 3 x 10-6 s-'). Note that, at those concentrations needed
to saturate PBP5, penicillin partially acylated BSA.
Specificity profile of the anti-(67 kDa t-PBP5) antibodies
Antibodies raised against the tryptic derivatives of PBP5 (see
the Materials and methods section) reacted only with PBP5 (plus
two weaker bands) but not with the other PBPs present in the
membranes of Ent. hirae R40 (Fig. 1, lane 3). They also reacted
with all the tryptic-digest PBP5 fragments described above (Fig.
1, lanes 10-12).
Amino acid sequencing data and PCR amplification
The peptide fragments (usually 600 pmol) separated by SDS/
PAGE as shown in Fig. 1 (lanes 4-to 12) were electroblotted and
the amino acid sequence of the N-terminal region of each
individual peptide was determined by automated microsequence
analysis (Fig. 2). On the basis of these data, the two oligo-
nucleotides shown in Fig. 3 were synthesized. Oligonucleotide 1
had a BamHI site at the 5'-end and coded for the sequence
Ql 1-K17 of the 60 kDa t-PBP5. Oligonucleotide 2 had an EcoRI
site at the 5'-end and was complementary to the nucleotide
sequence coding for the sequence E16-L23 of the 44 kDa
t-PBP5. Amplification by the PCR technique with the oligo-
iPCRI Pstl/Sstl
-4 "SstIl/PstI





Fig. 4. Restriction map of pDML540 and strategy used for nucleotide
sequencing of the Ent. hirae R40 PBP5-encoding gene
nucleotides as primers and the Ent. hirae R40 DNA as template
generated a 476 bp DNA segment the sequence of which trans-
lated into a 155-amino acid-residue segment. This peptide, called
PBP5-PCR, is also shown in Fig. 3.
Gene cloning and sequencing
The Ent. hirae R40 DNA (2 ,tg) was partially digested with
EcoRI, the DNA fragments were inserted into pBR322 (1 ,ug)
previously cut by EcoRI and dephosphorylated, and the ligation
mixture (5 ,d out of 20 ,l) served to transform Esh. coli HB1O1
cells. Transformants were selected on solid LB medium con-
taining 50,ug of ampicillin/ml, transferred on to nylon filters
(Amersham International) and screened with the [y-32P]ATP-
labelled 24-mer probe (Fig. 3). Hybridization was carried out at
50 °C and post-hybridization washing at 65 °C (Tn 72 °C). Of the
2150 ampicillin-resistant Esch. coli transformants tested, one
clone gave a strong positive reaction with the probe. The
harboured plasmid pDML540 (11.4 kb) had acquired a 7.1 kb
insert. pDML540, whose restriction map is shown in Fig. 4, was
digested separately by HincII and by PstI and SstI. The HinclI
2.6 kb DNA fragment and the PstI-SstI 0.5 kb DNA fragment
hybridized with the probe (results not shown). Nucleotide
sequencing of the PstI-SstI fragment allowed, on the basis of the
position of the PstI site in the PBP5-PCR product, establishment
of the orientation of the PBP5-encoding gene, from PstI to SstI.
The HincIl 2.6 kb DNA fragment was sequenced on both strands,
by use of the strategy also shown in Fig. 4. A 2034-nucleotide-
residue open reading frame (Fig. 5) started at position 334 with
an ATG codon and terminated at position 2368 with a TAG stop
codon.
Amino acid sequence of PBP5 and sequence-similarity searches
The open reading frame translated into a 678-amino acid-
residue protein. As derived from the amino acid sequence (Fig.
5), the 67 kDa, 60 kDa, 44 kDa, 32 kDa and 30 kDa peptide
fragments were produced by tryptic cleavage ofthe bonds K76-T,
1991
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(-35) (-10) RBS M K R S D N H R R 9
TTAr"CAAGCGATT 1C1'ATGGTAAAATGATAGAAG1AAGATAAAAATGTGACGAGGGAAAATGMAAAAAGTGAATATCTAGG
241 360
N K T G V Y L T S A L V L V L A A G G G Y F Y Y Q K T Q E K Q V V S A G E K K I 49
AACAAGACIGGTGTloATCTAACAAGCGCCrlGGGTTCITGCGGCrGGTGGCGGGTAlolACTATCAAAAAMCGCAAGAAGAGCAAGTGGlsTCGCAGGAGAAAAAAMGATC
361 480
Q Q F A E R L S T G D Y K K A M S Y T Q I H S Q T K K T I S E K E A L E K Y Q N 89
C,AACAGlTIGCGGAACGll:GAGTAACTGGTATTTAAAGGCGATGTCATACACGCAAATTCAlTCACAGACTAAGAAGACAA71CTGAAAAAGAAGCTCTTGAAAAATACCAAAAT
481 60
I Y G A V A I K G L E I S N L K V T K K D S E T Y S F S Y K A K M N T S L G E L 129
ATTACGGAGCrGTGGCCATAAAAGGCITGGAAATCI CTAAT1AAAAGTGACGAAAAAAG ATAGTGAAAMATCUTCIATAAAGCTAAATGAATAGAAAGGCGAAr
601 Hindlll 720
K D L S Y K G T L T N K N D Q I K I N W Q P N L I F P Q M E D T D K V S L T S K 169
AAAGACCIATCATATAAAGGGAC lGACAMTAAGTAGATCMTGTCAACMTGGACGACTTGAT= CCrCAA TGGAAGATACAGACAGTAAGTCrGACrAGTAG
721 840
K A K R G D I L D R N G K K L A T T G K L K Q L G I V P R K L G K K E E K T A N 209
GAAGCTrAAAAGAGG;CGATATCCITGATCGAAATGGAAAGAAA77AGCAACGACGGCAATGAAACAGTTAGGGATCG1TCCTAGAAAGCrGGGAGAAAAGAAGAGAAAACAGCAAAC
841 960
I K A I A A A F D L S E D E I N Q A I S Q S W V Q P D Y F V P L K I I D G Q T P 249
ATCAAAGCAATTCGCAGClblGATClsCAGAAGATGAAATCAATCAAGCr ATC TCTCAAAGlr?GGETACAACGGCA.iMCCAAAAATCATGATGGACAAACOr,
961 Pstl Probe 1080
E L P S G R A I Q E V D G R T Y P L G E R A A Q L I G Y V G D I S A E D I K K N 289
GAATTGCCAAGCGGACGAGCG;ATCCAAGAAGTTGATGGTCGCACCrATCCGTTAGGCGAACGAGCAGCGCAA7rGATrGGlTATGTTGGTGATATCTCAGCAGAAGATATCAAAAAGAAT
1081 1200
A E L S S N G K I G R S G L E M T Y D K E L R G T N G G K L S I T D A D G T E K 329
GAATTAATAGTAAGTAATGT>CGTTCGCGGATAC17TGCAAArGTGCAATGGAGGG AAATTGAGTATTAGTCGATGGAAGAA
1201 1320
K V L I D Q E V K N G Q D I K L T L D A D A Q K I A F D S L G G K A G S T V A T 369
GAAGTATTGATTGATCAAGAAGTGAAAAAIlCTlZGGGAACGITCAAGTCAI
1321 1440
S P K T G K L L V L A S S P S Y D P N K M T N G I S Q E D Y Q A Y T E N K D Q P 409
TCGCCAAAACGGGTGAGTTGlTAGTATTAGCGAGCTCrCAGTTATGATCCAAACAAAATGACAAATGGAATCrCAAGAAGAT'TATCAAGCCTATACGGAAAATAAAGATCAACCA
1441 Sstl 1560
F I S R F A T G Y A P G S T F K M I T A A I G L D N Q T L N P D E V L T I N G L 449
TTTATTAGTGTlGICCGGTTACGClrCCCGATCrCTAATGTCGCCATCGGA:07TAGATATAAGW GACAAiAGTATTGACGATCAATGGATTG
1561 160
K W Q K D Q S W G S Y Q V T R V S D V P Q V N L R N A M I Y S D N I Y K A Q E T 439
AAATGCAAAAAGACCAA TCATGGGGATCGTATCAAGTTA GCATGGCTCAAGTCAATCGAGAAAGCATGCATTTCAGTAATCTTATTATGGTCAAGAAC
1681 1800
L K M G E K K F R K G L N K F I F G E D L D L P I S M N P A Q I S N K D S F K S 529
TT,AAGGGAGAGA7CGGA AGG7AATAATTATM GGGAAGAIAATrTGCGACA TGAATCGCAATCCAATAGGATAGTTrAAG
1801 1920
E I L L A D T G Y G Q G( E L L I N P I Q Q A T K Y S V F A N N G N L V Y P K L E 569
GAAATCITAlrAGCAGATACTGGTTATGGGCAGGGAGAACIATTGATCAATCCGATCCAACAAGCAACGATGTAlTT=ICSAIATGAAT TCG _ATCAATAGA
1921 2040
K D K E T K V K Q N V I A S T A V Q T I L P D L K D V V Q D T N G T A H S L A T 609
ATGGATAAAGAAACGAAAGTTAAMCAAAATGTCATTGCrlTCAACAGCIGTACAGACGATTCTGCCAGATITGAAAGATGTTGTTCAAGATACGAATGGTACCGCTCATT. rAGCrAA=,
241 Pvul Kpnl 2160
L G I P I A A K T G T A E I K E K Q D E K G Q E N S F L F A V N P D T N G Y L K 649
17TAGGCATACCAATAGCAGCAMAAAAIG3GTACAGCGGAAATCAAAGAAAAACAAGATGAAAAAGGACAAGAAAATAGClrCCATTTGCTGTGAATCCGATACAAATGGTTATCrCATG
2160 2280





(3AGCITAGGAAACTM TC TMG GGAAATG ATAGCATATGTTGAC
2521 2580 Hincil
Fig. 5. Nucleotide sequence of the Ent. hirae R40 PBP5-encoding gene and deduced amino acid sequence of the protein
The potential promoter - 35, -10 hexamers, the Shine-Dalgarno sequence (RBS), the restriction sites and the probe used to screen the clones are
underlined. The inverted repeats of the putative transcription termination signal are indicated by horizontal arrows.
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N-Terminal domain
PBP5 ii KTGVYLTSALVLVLAAGGGYFYYQKTQEEQWSAGEKKIQQFAERLSTGD 60
PBP2' 1 MKKIKIVPLILIVVVVGFGIYFY......... ASKDKEINNTID&IEDKN 41
61 YKKAMSYTQIHSQTKKTISEXEALEKYQNIYGAVAIKGLEISNLKVTKKD 110
IlI I1 II




ll111111 11 11 liii4 1
139 DQSIHIENLKSERGKILDRNNVELANTGTKHRLGIVPKNVSKKD ..... Y 183
211 KAIAAAFDLSEEINQ... AISQSWVQPDYFVPLKIIDGQTPELPSGRAI 257
1111 111 11 1 1 1
184 KAIAKELSISEDYINNKNIKIGYKMIPSFHFKTVKKMDEYLSDFAKKFHL 233
258 . .QEVDGRTYPLGERAAQLIGYVGDISAEDIKKNA.. ELSSNG.KIGRSGL 303
234 TrNETEsRNYPLGKATSHLLGYVGPINSEELKQXEYKGYKDDAVIGKKGL 283
304 EMTYDKELRGTNGGKLSITDADGTEKEV ... LIDQEVKNGQDIKLTLDAD 350





PBP5 364 GSTVATSPKTGELLVLASSPSYDPNKMTNGISQEDYQAYTENKDQPFISR 413
11 I I11111 I I Ill I I I 11 1 1
PBP2' 347 GSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNK 396
414 FATGYAPdEiiMITAAIGDNQTLNPDEVLTINGLKWQKDQSWGSYQVT 463
397 FQITTSPGSTQILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVT 446
464 RVSV. PQVNLRNAMIIIYMAQEKGEKKFREGLNKFIFGEDLDL 512
447 RYEVVNGNIDLKQAIESDIFFARVALELGSKKFEKGMKKLGVGEDIPS 496
513 PISMNPAQISNKDSFKSEILLADTGYGQGELLINPIQQATMYSVFANNGN 562
111111 111111 111111 11111 11 1111
497 DYPFYNAQISNKN. LDNEILLADSGYGQGEILINPVQILSIYSALENNGN 545
563 LVYPKLEDDKErIKV. KQNVIASTAVQTILPDLKDVVQDT. . NGTAHSLAT 609
546 IIAPHLLKDTKNKVNKKNIISKENINLLNDGMQQVVNKTHKEDIYRSYAN 595
610 LGIPIAA rAEIKEKQDEKGQENSFLFAVNPl'NcYLM... ISMLEDK 656
I 11 111l 11 1 1 11
596 L.... IG,KLAELKMKQGETGGRQIGWFISYDKDNPNtuMMMAINVKDVQDK 641
657 AEGDSATKRAPELLQYLNQN 676
642 GMASYNAKISGKVYDELYEN 661
Fig. 6. Amino acid sequence alignment of the Ent. hirae R40 PBP5 and
Staph. aureus PBP2'
Vertical lines indicate strict identities. The S*XXK, SDN and
KT(S)G motifs the penicillin-binding domains are boxed.
K146-I, K288-N, K389-M and K406-D respectively. The Ent.
hirae R40 PBP5 had significant similarity in the primary structure
to the Esch. coli PBPs 2 [35] and 3 [36] (27% and 22% strict
identities respectively), the Strep. pneumoniae PBPs 2X [16] and
2B [37] (24% and 25 % respectively), the N. gonorrhoeae PBP2
[18] (25 %) and the methicillin-resistant Staph. aureus PBP2' [12]
(33 %). Alignment of the Ent. hirae PBP5 and the Staph. aureus
PBP2', by using the Bestfit program in the GCG package (gap
weight: 5.0; length weight: 0.3), generated 223 strict identities
(Fig. 6). The significance of the degree of similarity found
between the two aligned amino acid sequences was estimated
with the seqdp program ofGoad & Kanehisa [38]. The alignment
had scores of -400 for the N-terminal domains (27% strict
identities) and -490 for the C-terminal domain (40% strict
identities). These scores were 30 and 53 standard deviations
respectively above that expected from a run of 20 randomized
pairs of proteins having the same amino acid compositions as the
two domains under consideration.
DISCUSSION
Upstream from the ATG initiation codon of the Ent. hirae
R40 PBP5-encoding gene there occur nucleotide sequences that
are analogous to the canonical -35 and -10 promoter sequences
found in Esch. coli [39], lactococci [40] and pneumococci [41]. Of
the two potential -35 hexamers, that starting at position T261
fits best the known rules for an active promoter sequence. The
GGAGG pentamer located 11 nucleotide residues upstream
from the ATG codon has the characteristics of the Shine-
Dalgarno sequences found in Staph. aureus and Bacillus species
[42]. The TAG stop codon is followed by an inverted repeat,
which might act as a terminator.
The fl-lactamases of class A and the Streptomyces R61 low-
molecular-mass PBP of known three-dimensional structure have
a unique signature in the form of four conserved amino acid
groupings, which, as a result of the folding of the polypeptide
chain, are brought close to each other and define the enzyme
active site. The S*XXK motif, about 60 residues downstream
from the N-terminus of the protein, is central to the cavity with
the active-site serine S* located at the N-terminus of one a-helix.
The S(Y)XN motif on a loop that connects two a-helices forms
one side of the cavity. The triad K(H)T(S)G, about 60 residues
upstream from the C-terminus of the protein, occurs on the
innermost strand of a five-stranded fl-sheet and forms the other
side of the cavity. Finally, a peptide segment, the D/E motif,
containing two dicarboxylic amino acid residues occurs, in the
primary structure, downstream of the S(Y)XN motif and, in the
tertiary structure, on a loop or small a-helix at the entry of the
cavity [1,43].
Assuming that this model applies to the high-molecular-mass
PBPs, the methicillin-resistant Staph. aureus 670-amino acid-
residue PBP2' [12] consists of a - 345-amino acid-residue N-
terminal domain connected to a 325-amino acid-residue C-
terminal penicillin-binding domain and has the active-site serine
residue at position 405 (Fig. 6). Similarly, the penicillin-resistant
Ent. hirae R40 678-amino acid-residue PBP5 consists of a - 360-
amino acid-residue N-terminal domain connected to a 320-
amino acid-residue penicillin-binding domain and has the active-
site serine residue at position 422. Amino acid alignment and
sequence-similarity searches reveal that the N-terminal domains
and the C-terminal domains of PBP2' and PBP5 are very similar.
Alignment also highlights the occurrence of the conserved
S*XXK, SDN and KT(S)G motifs. E508 or E542 (in the
numbering of PBP5) are possible candidates for the E/D motif.
It has been proposed that the methicillin-resistant Staph.
aureus strains have imported an inducible high-molecular-mass
PBP2' and that the encoding gene has probably evolved by
recombination of a PBP gene of some bacterium and an inducible
8,-lactamase gene [12]. In contrast, the enterococcal PBP5 gene
seems to be constitutive. Whatever their origin, the Staph. aureus
PBP2' and Ent. hirae PBP5 are only about 25 times more
susceptible to penicillin than BSA. Each of these PBPs can take
over the functions needed for wall peptidoglycan assembly under
conditions where all the other PBPs are inactivated by reaction
with fl-lactam antibiotics. These high-molecular-mass PBPs prob-
ably represent the ultimate achievement in intrinsic resistance to
these antibiotics.
Tryptic cleavage of the K76-T77 bond causes release of PBP5
from the Ent. hirae R40 membranes in the form of a pencillin-
binding water-soluble derivative, showing that the membrane
anchor of the PBP is located upstream from K76. Comparison of
the molecular mass of the membrane-bound PBP (71 000 Da, as
derived from migration on SDS/PAGE) with that of the pre-
cursor (74862 Da), suggests that the precursor may undergo
processing by elimination of a 30-40-amino acid-residue peptide
at the N-terminus of the protein. This region possesses six
diamino acids between Ml and T12, a long G13-G29 hydro-
phobic segment and several putative leader-peptidase-cleavage
sites (S18-A19, A25-A26, A26-G27, S43-A44 or A44-A45) [44].
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The exact mode of membrane anchoring of PBP5 will remain
unknown as long as the membrane-bound form has not been
isolated and its N-terminal region has not been sequenced. Note
that immunological and penicillin-binding analyses (results not
shown) indicate that PBP5 is expressed in Esch. coli and co-
migrates with the natural form, thus suggesting that in Ent. hirae
R40 PBP5 is probably not processed.
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